Updates
-
-
As New Parents, Scheduling Activities Is More Important than Ever
The importance of keeping a consistent schedule cannot be understated. A solid daily routine can help you save time, be more effective, and reach ... Read more -
China Opens Blood Disease Platform, Collecting Patient Data to Improve Research and Treatment
The Analysis Group has partnered with China’s Institute of Hematology & Blood Diseases Hospital (IHBDH) to create the first blood disease research platform in that country. ... Read more -
Proper Nutrition Lacking in Children with Hemophilia in Iraqi Province, Study Says
Proper nutrition is lacking in almost half of children with hemophilia in Iraq, with a significant portion of these children underweight compared to peers and a ... Read more -
Here’s a Thumbs-up to Taking Back Control
You don’t have to look far to find people who are afraid of needles. There is something to be said about sharp, pointy things ... Read more -
Rare Disease Film Festival Highlights Patient and Researcher Unity
Rare disease-themed videos glowed on a large screen before an audience of people in wheelchairs, with crutches, and bearing oxygen tanks this Nov. 9 ... Read more
-
Your Joint Health Is Important Sponsored Post
Submitted by Takeda Every joint bleed matters 70% to 80% of all bleeds in ... -
Sharing Stories Comes with Responsibility
I attended the Hope for Hemophilia conference last weekend and met some wonderful people. ... -
Modified Clotting Factor X Slowed Bleeding in Mouse Model of Hemophilia A, Study Reports
A modified version of the coagulation protein factor X was able to significantly reduce ... -
I’m Bleeding, Believe Me
I recently attended a national conference for women with hemophilia. Common themes emerged as ... -
Adulting Is Hard, Especially with Chronic Illness
Many in my millennial generation dread adulting. The idea of surviving in the real ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Europe’s CHMP Recommends Approval of Hemlibra to Treat Hemophilia A
News
Europe’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion supporting the approval of Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in hemophilia A patients with factor VIII inhibitors. Hemlibra is a humanized monoclonal antibody that ... Read more